SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Mrsny Randall Ph.D.

(Last) (First) (Middle)
C/O APPLIED MOLECULAR TRANSPORT INC.
1 TOWER PLACE, SUITE 850

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/04/2020
3. Issuer Name and Ticker or Trading Symbol
Applied Molecular Transport Inc. [ AMTI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Scientific Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 3,060,000 I By Living Trust(1)
Common Stock 270,000 I By GRAT for spouse(2)
Common Stock 270,000 I By GRAT(3)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares are held directly by the Mrsny-Daugherty Living Trust for which Dr. Mrsny and his spouse are co-trustees and over which Dr. Mrsny and his spouse hold voting and dispositive power.
2. These share are held directly by the Ann Daugherty 2020 Annuity Trust for Dr. Mrsny's spouse serves as trustee and over which Dr. Mrsny's spouse holds voting and dispositive power.
3. These shares are held directly by the Randall Mrsny 2020 Annuity Trust for which Dr. Mrsny serves as trustee and over which Dr. Mrsny holds voting and dispositive power.
Remarks:
Date set forth above represents the effective date of issuer's initial public offering.
/s/Brandon Hants Attorney-in-Fact for Randall Mrsny Ph.D. 06/04/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.